1. Home
  2. DOMH vs CHEK Comparison

DOMH vs CHEK Comparison

Compare DOMH & CHEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DOMH
  • CHEK
  • Stock Information
  • Founded
  • DOMH 1967
  • CHEK 2004
  • Country
  • DOMH United States
  • CHEK Israel
  • Employees
  • DOMH N/A
  • CHEK N/A
  • Industry
  • DOMH Biotechnology: Pharmaceutical Preparations
  • CHEK Medical Electronics
  • Sector
  • DOMH Health Care
  • CHEK Health Care
  • Exchange
  • DOMH Nasdaq
  • CHEK Nasdaq
  • Market Cap
  • DOMH 83.3M
  • CHEK 4.4M
  • IPO Year
  • DOMH N/A
  • CHEK 2015
  • Fundamental
  • Price
  • DOMH $5.21
  • CHEK N/A
  • Analyst Decision
  • DOMH
  • CHEK
  • Analyst Count
  • DOMH 0
  • CHEK 0
  • Target Price
  • DOMH N/A
  • CHEK N/A
  • AVG Volume (30 Days)
  • DOMH 302.6K
  • CHEK 28.3K
  • Earning Date
  • DOMH 08-07-2025
  • CHEK 08-14-2025
  • Dividend Yield
  • DOMH 6.07%
  • CHEK N/A
  • EPS Growth
  • DOMH N/A
  • CHEK N/A
  • EPS
  • DOMH N/A
  • CHEK N/A
  • Revenue
  • DOMH $24,891,000.00
  • CHEK N/A
  • Revenue This Year
  • DOMH N/A
  • CHEK N/A
  • Revenue Next Year
  • DOMH N/A
  • CHEK N/A
  • P/E Ratio
  • DOMH N/A
  • CHEK N/A
  • Revenue Growth
  • DOMH 630.80
  • CHEK N/A
  • 52 Week Low
  • DOMH $0.83
  • CHEK $0.56
  • 52 Week High
  • DOMH $13.58
  • CHEK $3.04
  • Technical
  • Relative Strength Index (RSI)
  • DOMH 49.52
  • CHEK 41.81
  • Support Level
  • DOMH $5.08
  • CHEK $0.75
  • Resistance Level
  • DOMH $6.08
  • CHEK $0.86
  • Average True Range (ATR)
  • DOMH 0.53
  • CHEK 0.03
  • MACD
  • DOMH -0.04
  • CHEK 0.00
  • Stochastic Oscillator
  • DOMH 25.45
  • CHEK 19.59

About DOMH Dominari Holdings Inc.

Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Share on Social Networks: